Loading [Contrib]/a11y/accessibility-menu.js
JHEOR

Perspective

Value-based Reimbursement as a Mechanism to Achieve Social and Financial Impact in the Healthcare System
October 31, 2023 EDT
Value-based Reimbursement as a Mechanism to Achieve Social and Financial Impact in the Healthcare System
Ana Paula Beck de Silva EtgesHarry H. LiuPorter JonesCarisi A. Polanczyk

A thorough understanding of value-based reimbursement agreements as a mechanism is critical to achieving social impact while ensuring financial sustainability.

QALYs: The Math Doesn’t Work
July 27, 2023 EDT
QALYs: The Math Doesn’t Work
Tia G. SawhneyAngela DobesSirimon O'Charoen

Our review of the mathematical properties of QALYs leads us to conclude that QALYs are an inappropriate metric of cost-effectiveness and should not be the basis for healthcare policy decisions.

Drug Cost-Effectiveness Assessments Require Standards for Rigor and Inclusion
February 23, 2023 EDT
Drug Cost-Effectiveness Assessments Require Standards for Rigor and Inclusion
Tia Goss SawhneyNeil Thakur

ICER should reevaluate its reliance on quality-adjusted life-years and equal value of life years gained as measures of drug effectiveness.

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.